Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Do molecularly targeted agents in oncology have reduced attrition rates?

Literature DB >> 19008887

Do molecularly targeted agents in oncology have reduced attrition rates?

Ian Walker, Herbie Newell.

Abstract

Mesh：

Substances：
Antineoplastic Agents

Year: 2008 PMID： 19008887 DOI： 10.1038/nrd2758

Source DB: PubMed Journal: Nat Rev Drug Discov ISSN： 1474-1776 Impact factor: 84.694

× No keyword cloud information.

6 in total

1. The price of innovation: new estimates of drug development costs.

Authors: Joseph A DiMasi; Ronald W Hansen; Henry G Grabowski
Journal: J Health Econ Date: 2003-03 Impact factor: 3.883

2. Oncology's trials.

Authors: Bruce Booth; Robert Glassman; Philip Ma
Journal: Nat Rev Drug Discov Date: 2003-08 Impact factor: 84.694

Review 3. Can the pharmaceutical industry reduce attrition rates?

Authors: Ismail Kola; John Landis
Journal: Nat Rev Drug Discov Date: 2004-08 Impact factor: 84.694

Review 4. Economics of new oncology drug development.

Authors: Joseph A DiMasi; Henry G Grabowski
Journal: J Clin Oncol Date: 2007-01-10 Impact factor: 44.544

Review 5. Development trends for new cancer therapeutics and vaccines.

Authors: Janice M Reichert; Julia B Wenger
Journal: Drug Discov Today Date: 2007-10-18 Impact factor: 7.851

Review 6. Maximizing mouse cancer models.

Authors: Kristopher K Frese; David A Tuveson
Journal: Nat Rev Cancer Date: 2007-09 Impact factor: 60.716

6 in total

33 in total

Review 1. Hurdles in anticancer drug development from a regulatory perspective.

Authors: Bertil Jonsson; Jonas Bergh
Journal: Nat Rev Clin Oncol Date: 2012-02-21 Impact factor: 66.675

Review 2. Successful aging: Advancing the science of physical independence in older adults.

Authors: Stephen D Anton; Adam J Woods; Tetso Ashizawa; Diana Barb; Thomas W Buford; Christy S Carter; David J Clark; Ronald A Cohen; Duane B Corbett; Yenisel Cruz-Almeida; Vonetta Dotson; Natalie Ebner; Philip A Efron; Roger B Fillingim; Thomas C Foster; David M Gundermann; Anna-Maria Joseph; Christy Karabetian; Christiaan Leeuwenburgh; Todd M Manini; Michael Marsiske; Robert T Mankowski; Heather L Mutchie; Michael G Perri; Sanjay Ranka; Parisa Rashidi; Bhanuprasad Sandesara; Philip J Scarpace; Kimberly T Sibille; Laurence M Solberg; Shinichi Someya; Connie Uphold; Stephanie Wohlgemuth; Samuel Shangwu Wu; Marco Pahor
Journal: Ageing Res Rev Date: 2015-10-14 Impact factor: 10.895

Review 3. Molecular imaging in clinical trials.

Authors: Debra Josephs; James Spicer; Michael O'Doherty
Journal: Target Oncol Date: 2009-09-21 Impact factor: 4.493

4. The (un)targeted cancer kinome.

Authors: Oleg Fedorov; Susanne Müller; Stefan Knapp
Journal: Nat Chem Biol Date: 2010-03 Impact factor: 15.040

5. Emphasising the European Union's Commitment to Cancer Research: a helicopter view of the Seventh Framework Programme for Research and Technological Development.

Authors: Jan-Willem van de Loo; Dominika Trzaska; Karim Berkouk; Maria Vidal; Ruxandra Draghia-Akli
Journal: Oncologist Date: 2012